Tiny Carriers, Big Impact: How Tannerella forsythia Extracellular Vesicles Drive Oral Diseases, and Beyond

Periodontitis influences systemic health through mechanisms that extend far beyond the periodontal pocket, yet the vehicles that mediate this dissemination remain incompletely defined. Within the “red complex” of periodontitis, Tannerella forsythia (Tf) has long been overshadowed by Porphyromonas gingivalis and Treponema denticola, and its extracellular vesicles (EVs) have been correspondingly neglected. This review synthesizes a decade of evidence to reposition Tf EVs as a distinct nanoscale virulence-delivery platform. Their biogenesis couples outer-membrane budding to the type IX secretion system (T9SS), and the crystalline surface layer (S-layer) appears to be actively reprogrammed—rather than passively shed—to accommodate vesicle curvature, a mechanism so far supported by compositional evidence. Their cargo is selectively enriched in T9SS substrates, TonB-dependent receptor/SusD-like nutrient-acquisition proteins, and extensively O-glycosylated virulence factors. Mechanistically, as demonstrated directly at the vesicle level in cellular models, Tf EVs engage Toll-like receptor 2 (TLR2), autonomously prime and activate the inflammasome, and drive IL-12-dependent Th1 polarization. These properties define a “purely pro-inflammatory” immunological identity that distinguishes Tf EVs from those of P. gingivalis and Fusobacterium nucleatum. Signature cargo, including BspA, miropin, and PepO, suggests potential links between Tf EVs and cardiovascular, articular, and pulmonary diseases; however, these systemic associations are currently inferred mainly from whole-cell, isolated-virulence-factor, or epidemiological evidence, rather than from direct Tf EV-level experiments, and are therefore presented here as testable hypotheses. We critically appraise isolation and standardization practices, delineate priority gaps such as unverified vesicle subtypes and unexplored small RNA cargo, and propose a four-step roadmap from subtype isolation to clinical cohorts. Tf EVs warrant recognition as an independent research object and a candidate druggable target for periodontitis, whereas their contribution to its systemic comorbidities awaits direct causal validation at the EV level.